← 返回

CD4(+) T 细胞帮助髓系介导的免疫逃逸肿瘤杀伤

英文原题:CD4(+) T cells help myeloid-mediated killing of immune-evasive tumors.

查看英文原题

CD4(+) T cells help myeloid-mediated killing of immune-evasive tumors.

PubMed 2023/08/05(内容时间) Trends Cancer Q1 · IF 21.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

在最近发表于Nature的一项研究中,Kruse等人展示了一种由少量CD4+效应T细胞协调的间接杀瘤机制。这些CD4+T细胞不仅能将髓系细胞重编程为IFNγ诱导的抗原提呈细胞,还能将其重编程为表达iNOS的杀瘤效应细胞,从而能够清除免疫逃逸性肿瘤。

展开英文摘要原文

In a recent study published in Nature, Kruse et al. demonstrated an indirect tumor-killing mechanism orchestrated by a small number of CD4 + effector T cells. These CD4 + T cells can reprogram myeloid cells not just into IFNγ-induced antigen-presenting cells but also into iNOS-expressing tumoricidal effectors that can eradicate immune-evasive tumors.

论文信息

作者
Wu K、Fong L
第一作者单位
Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.United States
通讯作者单位
Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. Electronic address: lawrence.fong@ucsf.edu.United States
文献类型
美国 NIH 资助研究 · 非美国政府资助研究
期刊
Trends in cancer2023 Oct
原文标识
PubMed 37544796 · DOI 10.1016/j.trecan.2023.07.013